Status:

COMPLETED

Study to Assess the Efficacy and Safety of Three Doses of PT001 in Japanese Subjects With Moderate to Severe COPD

Lead Sponsor:

Pearl Therapeutics, Inc.

Conditions:

Chronic Obstructive Pulmonary Disease

Eligibility:

All Genders

40-80 years

Phase:

PHASE2

Brief Summary

The overall objective of this study was to assess the efficacy and safety of GP MDI relative to placebo in Japanese subjects with moderate to severe COPD. Each subject received the 4 separate study tr...

Detailed Description

This was a randomized, double-blind, chronic-dosing (7-day), four-period, four-treatment, placebo-controlled, crossover, multi-center study to assess the efficacy and safety of 3 doses of GP MDI (28.8...

Eligibility Criteria

Inclusion

  • Clinical history of COPD with a moderate to severe classification
  • Current and former smokers with a history of at least 10 pack-years of cigarette smoking.
  • Post-bronchodilator FEV1 must be ≥30% and \<80% predicted normal value-

Exclusion

  • Pregnancy
  • Primary asthma diagnosis; Poorly controlled COPD defined as acute worsening of COPD that required treatment with corticosteroids or antibiotics in the 6-week interval prior to Screening or between Screening and Visit 2;
  • Clinically significant abnormal ECG
  • Other active pulmonary disease such as active tuberculosis, lung cancer, bronchiectasis, sarcoidosis, lung fibrosis, primary pulmonary hypertension, interstitial lung disease, and uncontrolled sleep apnea; Cancer that was not in complete remission for at least 5 years;
  • Diagnosis of angle closure glaucoma
  • A documented myocardial infarction within 1 year of Screening.

Key Trial Info

Start Date :

January 28 2015

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 5 2015

Estimated Enrollment :

66 Patients enrolled

Trial Details

Trial ID

NCT03256552

Start Date

January 28 2015

End Date

September 5 2015

Last Update

January 23 2018

Active Locations (18)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 5 (18 locations)

1

Pearl Investigative Site

Fukuoka, Fukuoka, Japan

2

Pearl Investigative Site

Iizuka-shi, Fukuoka, Japan

3

Pearl Investigative Site

Mizunami-shi, Gifu, Japan

4

Pearl Investigative Site

Sapporo, Hokkaido, Japan

Study to Assess the Efficacy and Safety of Three Doses of PT001 in Japanese Subjects With Moderate to Severe COPD | DecenTrialz